These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7040093)

  • 41. Antilymphoid globulin in the therapy of secondary disease.
    Corneci I; Andrian T; Costachel O; Feteanu A
    Transplant Proc; 1971 Mar; 3(1):422-6. PubMed ID: 4398500
    [No Abstract]   [Full Text] [Related]  

  • 42. Recovery of T cell populations after acute graft-vs-host reaction.
    Hakim FT; Payne S; Shearer GM
    J Immunol; 1994 Jan; 152(1):58-64. PubMed ID: 8254206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Estimation of the graft-versus-host reaction in the mouse liver by the hypertrophy of portal draining lymph nodes].
    Fedorov GN; Chaĭkovskiĭ IuIa; Shcherbakov VIa; Antonova VI
    Biull Eksp Biol Med; 1982 Jan; 93(1):75-7. PubMed ID: 7066507
    [No Abstract]   [Full Text] [Related]  

  • 44. [Study on graft-versus-leukemia effects of donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation].
    Du B; Li D; Xu K
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):403-7. PubMed ID: 11718089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure to produce graft versus host reaction with splenic cells from athymic nude mice.
    Sekiguchi M; Fujii G; Sude K; Suzuki K
    Jpn J Exp Med; 1977 Dec; 47(6):531-3. PubMed ID: 24771
    [No Abstract]   [Full Text] [Related]  

  • 47. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
    Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
    Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Graft vs host reaction and graft vs host diseases].
    Sakagami K; Orita K
    Nihon Rinsho; 1985 Jan; 43(1):97-103. PubMed ID: 3886972
    [No Abstract]   [Full Text] [Related]  

  • 50. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of manganese dichloride on the graft vs host activity of splenic lymphocytes in mice].
    Divanian Kh; Boshnakova E
    Eksp Med Morfol; 1988; 27(4):17-9. PubMed ID: 3266148
    [No Abstract]   [Full Text] [Related]  

  • 53. Preparation of xenogeneic antibodies eliminating lymphocytes from human bone marrow selectively.
    Wulff JC; Anderson M; Held H; Müller-Hermelink HK; Schlaak M; Müller-Ruchholtz W
    Transplant Proc; 1981 Mar; 13(1 Pt 1):230-3. PubMed ID: 7022829
    [No Abstract]   [Full Text] [Related]  

  • 54. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
    Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Autoreactivity of splenic cells of old rats and animals treated with hydrocortisone].
    Meĭlikhova AN; Maianskiĭ DN; Kozlov VA
    Biull Eksp Biol Med; 1981 Jun; 91(6):706-7. PubMed ID: 6974017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients.
    Doney KC; Weiden PL; Storb R; Thomas ED
    Transplantation; 1981 Feb; 31(2):141-3. PubMed ID: 7020176
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment and pretreatment of graft-versus-host reaction by antilymphocyte serum.
    Haskovcová H; Nouza K
    Folia Biol (Praha); 1970; 16(6):397-406. PubMed ID: 4395162
    [No Abstract]   [Full Text] [Related]  

  • 59. [Reduced graft-versus-host reaction after transplantation of cryopreserved allogeneic hematopoietic tissue].
    Ignasheva LP; Fedotenkov AG; Danilova LA
    Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):34-8. PubMed ID: 6757916
    [No Abstract]   [Full Text] [Related]  

  • 60. Synergistic effect of antilymphocyte serum and the graft-versus-host reaction on murine skin allograft survival.
    Lapp WS
    Transplantation; 1973 May; 15(5):469-73. PubMed ID: 4145550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.